Evotec’s Biomarkers in Clinical Trials Platform delivers GCP-compliant and exploratory biomarker assays to support clinical development with precision and regulatory confidence. From validated immunoassays and immunogenicity testing to multiplex flow cytometry, transcriptomics, and proteomics, the platform ensures robust biomarker data to guide decision-making across all phases of clinical research. With expert teams and advanced technologies, Evotec enables reliable trial outcomes and accelerates patient-centered therapies.